Guardant Health News Update

Listing Websites about Guardant Health News Update

Filter Type:

NASDAQ: GH26.24USD▲ +0.49 (+1.90%) today26.57▲ 0.33 (1.26%)After Hours · May 16, 7:52 PM EDT · Market ClosedIn-depth analysisDayWeekMonthYear5 YearMaxProjectionThis chart isn’t available.Loading…Open25.74P/E-Vol3.35 MHigh27.3152wk High41.06Avg Vol1.99 MLow25.1652wk Low15.81Mkt Cap3.21 BSee more on MSN · Data from Refinitiv · Price in USD · Market closed · DisclaimerGuardant Health, Inchttps://investors.guardanthealth.com/pressGuardant Health Reports First Quarter 2024 Financial Results and

(3 days ago) WEBRevenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Guardant Health, Inc. (Nasdaq: GH), a leading precision …

https://www.msn.com/en-us/money/watchlist?tab=Related&id=bn9sec&ocid=ansMSNMoney11&duration=1D&src=b_secdans&relatedQuoteId=bn9sec&relatedSource=MlAl

Category:  Health Show Health

Guardant Health, Inc. (GH) Latest Stock News & Headlines - Yahoo …

(Just Now) WEBGet the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investing decisions. News. Today's news; US; Guardant Health, Inc. …

https://finance.yahoo.com/quote/GH/news/

Category:  Health Show Health

Guardant Health Reports First Quarter 2024 Financial Results and

(3 days ago) WEB2024 Guidance. Guardant Health now expects full year 2024 revenue excluding screening to be in the range of $675 to $685 million, representing growth of …

https://finance.yahoo.com/news/guardant-health-reports-first-quarter-200500610.html

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health Announces Preliminary …

(3 days ago) WEBFull year revenue growth of 25% driven by clinical volume growth of 39% Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today …

https://investors.guardanthealth.com/press-releases/press-releases/2024/Guardant-Health-Announces-Preliminary-Fourth-Quarterand-Full-Year-2023-Results/default.aspx

Category:  Health Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(Just Now) WEBPALO ALTO, Calif., April 22, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics …

https://finance.yahoo.com/news/fda-advisory-panel-review-guardant-125200837.html

Category:  Health Show Health

Guardant Health Reports Fourth Quarter and Full Year 2022 …

(6 days ago) WEBQ4 clinical and biopharma volumes up 41% and 24% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-2023-Outlook/default.aspx

Category:  Health Show Health

Guardant Health Announces Preliminary Fourth Quarter and Full

(1 days ago) WEBFull year 2022 preliminary unaudited financial results. For the twelve-month period ended December 31, 2022, as compared to the same period of 2021: Revenue of …

https://www.nasdaq.com/press-release/guardant-health-announces-preliminary-fourth-quarter-and-full-year-2022-results-2023

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(5 days ago) WEBThe forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health …

https://www.businesswire.com/news/home/20240516838593/en/Guardant-Health-to-present-real-world-data-supporting-performance-of-Shield%E2%84%A2-blood-test-for-colorectal-cancer-screening-at-2024-Digestive-Disease-Week

Category:  Health Show Health

Buy Rating Affirmed for Guardant Health Amid Strong Shield Test

(7 days ago) WEBGuardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing …

https://markets.businessinsider.com/news/stocks/buy-rating-affirmed-for-guardant-health-amid-strong-shield-test-prospects-and-positive-eclipse-study-results-1033164379

Category:  Health Show Health

Guardant Health Announces ECLIPSE Study Update Call on May 9, …

(7 days ago) WEBGuardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ …

https://www.businesswire.com/news/home/20230504006138/en/

Category:  Health Show Health

Guardant Health Provides Update on COBRA Study, Restates …

(6 days ago) WEBGuardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ …

https://www.businesswire.com/news/home/20230901319507/en/Guardant-Health-Provides-Update-on-COBRA-Study-Restates-Confidence-in-MRD-Test/

Category:  Health Show Health

Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript

(6 days ago) WEBGuardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ETCompany Participants. Helmy Eltoukhy - Chairman & Co-Chief …

https://seekingalpha.com/article/4691776-guardant-health-inc-gh-q1-2024-earnings-call-transcript

Category:  Health Show Health

Guardant Health Announces $90.7 Million Registered Direct …

(6 days ago) WEBPALO ALTO, Calif., December 21, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that it has entered into a common stock …

https://finance.yahoo.com/news/guardant-health-announces-90-7-140000054.html

Category:  Health Show Health

2024-05-16 NDAQ:GH Press Release Guardant Health Inc

(2 days ago) WEBGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://stockhouse.com/news/press-releases/2024/05/16/guardant-health-to-present-real-world-data-supporting-performance-of-shield-tm

Category:  Health Show Health

Guardant Health Reports Third Quarter 2022 Financial Results

(5 days ago) WEBQ3 clinical and biopharma volumes up 42% and 40% year over year Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Reports-Third-Quarter-2022-Financial-Results/default.aspx

Category:  Health Show Health

Guardant Health to present real-world data supporting - BioSpace

(2 days ago) WEBGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://www.biospace.com/article/releases/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week/

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(9 days ago) WEBGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the …

https://markets.financialcontent.com/stocks/article/bizwire-2024-5-16-guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week

Category:  Health Show Health

Guardant Health Announces Preliminary Fourth Quarter and Full …

(Just Now) WEBPALO ALTO, Calif., January 08, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced preliminary, unaudited results for the …

https://finance.yahoo.com/news/guardant-health-announces-preliminary-fourth-140000079.html

Category:  Health Show Health

Cancer Test Focused Guardant Health Stock Falls On FDA AdCom …

(6 days ago) WEBGuardant Health surpasses Q4 2023 revenue expectations, reporting $155.1 million. Precision oncology revenue is up 25% to $142.2 million. Adjusted EPS …

https://markets.businessinsider.com/news/stocks/cancer-test-focused-guardant-health-stock-falls-on-fda-adcom-update-for-colorectal-test-1033098815

Category:  Health Show Health

Guardant Health (NASDAQ:GH) Trading 4.7% Higher - MarketBeat

(9 days ago) WEBOn average, research analysts anticipate that Guardant Health, Inc. will post -3.49 earnings per share for the current fiscal year. Insider Activity. In related news, …

https://www.marketbeat.com/instant-alerts/nasdaq-gh-percent-advance-2024-05-16/

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health Announces Shield™ Blood …

(Just Now) WEBHighly sensitive Shield test offers convenient screening method that can be completed with simple blood draw, helping overcome barriers to compliance Test …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-Announces-Shield-Blood-Test-Available-in-US-to-Detect-Early-Signs-of-Colorectal-Cancer-in-Average-Risk-Adults/default.aspx

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(Just Now) WEBPALO ALTO, Calif., May 16, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present data from two real …

https://finance.yahoo.com/news/guardant-health-present-real-world-120500882.html

Category:  Health Show Health

Public Policy - GuardantHealth

(2 days ago) WEBRead the latest news, announcements, and stories from Guardant Health. Press Releases (Task Force) updates its recommendations doesn't reflect today's pace of innovation. …

https://guardanthealth.com/about/democratize-cancer-screening/

Category:  Health Show Health

Guardant Health Provides Update on COBRA Study, Restates …

(2 days ago) WEBPALO ALTO, Calif., September 01, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today issued the following statement about …

https://finance.yahoo.com/news/guardant-health-provides-cobra-study-194600644.html

Category:  Health Show Health

Filter Type: